XML 29 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue
Expenses:        
Cost of sales
Research and development 1,819
Selling, general and administrative 43,098 25,984 165,264 89,850
Total expenses 43,098 25,984 165,264 91,669
Loss from operations (43,098) (25,984) (165,264) (91,669)
Other income (expense)        
Interest income (expense) 281 281
281 281
Net loss $ (42,817) $ (25,984) $ (164,983) $ (91,669)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares) 67,022,568 45,572,568 53,665,425 45,572,568